|
|
|
|
| |  |
Janet Linn focuses her practice on intellectual property litigation, counseling and opinion work. She covers the full range of intellectual property law, including patent, trade secrets, trademark, unfair competition, copyright, false advertising and related antitrust issues. She has litigated cases in a broad spectrum of technologies, from consumer products, computer programs, and medical devices, to gas turbines and noise cancellation headphones. In addition, Janet has substantial experience in trademark prosecution and inter partes proceedings, copyright registration and appeals to the Copyright Office.
-
Advises with particular expertise in pharmaceutical patent litigation under the Hatch-Waxman Amendments, and the interplay between FDA and patent law, having litigated Hatch-Waxman cases for more than 15 years;
-
Litigates in the pharmaceutical area and has been trial counsel in patent, trade secret and antitrust litigations; advised on patent prosecution, Orange Book listings, and Citizen’s Petitions; performed pre-litigation audits; and provided patent validity and infringement opinions to pharmaceutical companies as well as financial institutions following pharmaceutical patent issues.
Intellectual Property
Intellectual Property Litigation
Food & Drug Administration Regulatory
Litigation
Life Sciences
LL.M. in Trade Regulation, New York University School of Law, 1983
J.D., State University of New York at Buffalo School of Law, 1977, magna cum laude, Phi Beta Kappa
M.A., University of Wisconsin, 1974
B.A., State University of New York, 1972
New York
U.S. District Court for the Southern and Eastern Districts of New York
U.S. Court of Appeals for the Federal Circuit
Chair of the Patents Committee of the Association of the Bar of the City of New York
Women in Intellectual Property
Selected for inclusion in New York Super Lawyers
- “Competition By Litigation: Lessons from the Smartphone Patent Wars,” Intellectual Property Today, May 2010.
- “En Banc Federal Circuit Cases: Clearer Law or Confusion,” presented at the Association of the Bar of The City of New York program, April 2013.
- “IP in China” presented at the Managing Intellectual Property Conference, April, 2013.
- “Patent Law for Non-Patent Lawyers,” presented for the New York City Bar CLE program, March 2013.
- “Pivotal Court Cases for FDA Practitioners: 2012-2013 Updates,” presented at the annual meeting of the Food, Drug and Cosmetic Law Section of the New York Bar Association, January 2013.
- “Therasense v. Becton Dickinson: Consequences for Patent Litigation,” presented to the Eastern New York Intellectual Property Law Association, November 2012.
- “Developments in Pharmaceutical and Biotech Patent Law 2012,” presented for the Practicing Law Institute, April 5, 2012.
- “Current IP Trends for FDA Practitioners,” presented at the annual meeting of the Food, Drug and Cosmetic Law Section of the New York Bar Association, January 2011.
- ”The Patent Reform Act (And Other Developments): The Implications for Your Patent Practice,” program Co-Chair of the New York City Bar CLE program, January 2011.
- “Biologics and Biosimilars, the New Approval Pathway,” co-presenter at the New York State Bar Association Food and Drug Law Section, January 2011.
- “Getting the Most Out of Your Patent License,” presented at the Association of the Bar of The City of New York program, December 2010.
- “IP Lawyers Weigh In On Microsoft V. I4i Ruling,” quoted, Law360, June 9, 2011.
- “Microsoft Asks for Rehearing as Word Injunction Takes Effect” quoted, E-Commerce Times, January 12, 2010.
- “Microsoft Loses Battle of Word in Texas Court” quoted, E-Commerce Times, August 12, 2009; “Can Microsoft Keep Its Word?” E-Commerce Times, August 14, 2009; “Microsoft Lawyers Start to Sweep Up Word Mess” E-Commerce Times, August 19, 2009.
|
Back to Top
|
 |
 
|
|
|
|
